METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES
US-2024076619-A1 · Mar 7, 2024 · US
Methods and compositions for treating congestive heart failure
US2016256497A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016256497-A1 |
| Application number | US-201615093301-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 7, 2016 |
| Priority date | Nov 22, 2004 |
| Publication date | Sep 8, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compositions and methods for treating congestive heart failure are provided herein.
First claim
Opening claim text (preview).
1 . A method of treating a patient suffering from congestive heart failure, comprising contacting a region of the patient's heart with an amount of a cultured three-dimensional tissue that comprises living cells effective to treat at least one clinical symptom associated with heart failure. 2 .- 33 . (canceled)
Assignees
Inventors
Classifications
Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin · CPC title
Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691) · CPC title
characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title
Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells · CPC title
Muscle cells, e.g. smooth muscle cells · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016256497A1 cover?
- Compositions and methods for treating congestive heart failure are provided herein.
- Who is the assignee on this patent?
- Univ Arizona
- What technology area does this patent fall under?
- Primary CPC classification A61K35/34. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Sep 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).